There were 1,920 press releases posted in the last 24 hours and 442,985 in the last 365 days.

Contact

Please use this form to send email to PR contact of this press release:
SELLAS Announces U.S. FDA Rare Pediatric Disease Designation Granted to SLS009 for the Treatment of Pediatric Acute Lymphoblastic Leukemia

TO:



FROM:

Please check your email address!

Please, do not fill this field.

Please, do not change this field.

Please, do not fill if your javascript is turned off.

captcha image